🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

Recruitingn/aAges 18 Years - 120 YearsAllGrupo Espanol de Investigacion en Sarcomas
NCT04181970 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Post-authorisation, multicentric, observational, retrospective and prospective study to assess quality of care of sarcoma patients in expert and non-expert centers by analysing correlation of quality items and outcomes such as relapse free survival, overall survival, percentage of amputation, etc. Expert pathology peer review will be performed to detect differences between expert and non-expert centers as well as differences in treatment and patient prognosis. Tumor samples of 4 types of sarcoma would also be included in translational research to detect biomarkers and produce preclinical models.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Histological diagnosis of soft-tissue sarcoma, GIST or bone sarcoma (all subtypes) from January 2005 until Juny/September 2023. * ≥ 18 years * Available clinical and treatment information Exclusion Criteria: There is no exclusion criteria
💊

What it tests

  • Quality assessment
📍

Where

9 sites
Alexander Fleming Sa
Buenos Aires, Argentina
A C Camargo
São Paulo, Brazil
Hospital San Vicente de Paúl
Heredia, Costa Rica
Centre Leon Berard
Lyon, France
Instituto Ortopedico Rizzoli
Bologna, Italy
Insituto Nazionale Di Tumore
Milan, Italy
Instituto Nacional de Cancerología
Mexico City, Mexico
Instituo Nacional de enfermedades Neoplásicas
Surquillo, Peru

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy